China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a report released on Friday morning. The brokerage issued a hold rating on the stock.

China Pharma Price Performance

Shares of NYSE:CPHI opened at $0.24 on Friday. The company’s fifty day moving average is $0.22 and its two-hundred day moving average is $0.22. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.